Abstract
5-Aminolevulinic acid (ALA) is an endogenous natural amino acid, and has recently been attracting attention as a new-generation photosensitive substance for photodynamic diagnosis (PDD). In the urology field, ALA-mediated PDD (ALA-PDD) has already been approved for the intraoperative diagnosis of non-muscle invasive bladder cancer (NMIBC) as a novel fluorescence-guided navigation technology approved in Europe and United States, whereas in Japan, ALA is waiting for approval as a photosensitizer for bladder cancer. Moreover, ALA-PDD is also clinically applied for the diagnosis of upper urinary tract cancer, prostate cancer, and renal cancer. This chapter outlines ALA-PDD for urinary bladder cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.
Matsuda A, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H, et al. Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2013;43:328–36.
Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011;103:1827–39.
FerrÃs J, Berbel O, Alonso-López J, Garcia J, Ortega JA. Environmental non-occupational risk factors associated with bladder cancer. Actas Urol Esp. 2013;37:579–86.
Malik Z, Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer. 1987;56:589–95.
Kriegmair M, Baumgartner R, Knuechel R, Steinbach P, Ehsan A, Lumper W, et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology. 1994;44:836–41.
Fukuhara H, Inoue K, Kuno T, Kamei M, Shimamoto T, Fukata S, et al. Photodynamic diagnosis of positive margin during radical prostatectomy: preliminary experience with 5-aminolevulinic acid. Int J Urol. 2011;18:585–91.
Inoue K, Ashida S, Fukuhara H, Iiyama T, Miyamura M, Kurabayashi K, et al. Application of 5-aminolevulinic acid (ALA) mediated photodynamic diagnosis (PDD) to robot-assisted laparoscopic radical prostatectomy (RALP). Urology. 2013;82:1175–8.
Hoda MR, Popken G. Surgical outcomes of fluorescence-guided laparoscopic partial nephrectomy using 5-aminolevulinic acid-induced protoporphyrin IX. J Surg Res. 2009;154:220–5.
Inoue K, Karashima T, Kamada M, Kurabayashi A, Ohtsuki Y, Shuin T. Clinical experience with intravesical instillations of 5-aminolevulinic acid (5-ALA) for the photodynamic diagnosis using fluorescence cystoscopy for bladder cancer. Nippon Hinyokika Gakkai Zasshi. 2006;97:719–29.
Inoue K, Kuno T, Fukuhara H, Hamaguchi T, Fukata S, Karashima T, et al. Clinical experience with transurethral resection of bladder tumor (TUR-Bt) guided by photodynamic diagnosis (PDD). Nippon Hinyokika Gakkai Zasshi. 2009;100:661–70.
Inoue K, Fukuhara H, Shimamoto T, Kamada M, Iiyama T, Miyamura M, et al. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for non-muscle invasive bladder cancer. Cancer. 2012;118:1062–74.
Kausch I, Sommerauer M, Montorsi F, Stenzl A, Jacqmin D, Jichlinski P, et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol. 2010;57:595–606.
Mowatt G, N’Dow J, Vale L, Nabi G, Boachie C, Cook JA, et al. Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis. Int J Technol Assess Health Care. 2011;27:3–10.
Burger M, Grossman HB, Droller M, Schmidbauer J, Hermann G, Drăgoescu O, et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol. 2013;64:846–54.
Rink M, Babjuk M, Catto JW, Jichlinski P, Shariat SF, Stenzl A, et al. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur Urol. 2013;64:624–38.
Zaak D, Hungerhuber E, Schneede P, Stepp H, Frimberger D, Corvin S, et al. Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions. Cancer. 2002;95:1234–8.
Hungerhuber E, Stepp H, Kriegmair M, Stief C, Hofstetter A, Hartmann A, et al. Seven years’ experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology. 2007;69(2):260–4.
Denzinger S, Burger M, Walter B, Knuechel R, Roessler W, Wieland WF, et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acidinduced fluorescence diagnosis: 8-year results of prospective randomized study. Urology. 2007;69:675–9.
Rick K, Sroka R, Stepp H, Kriegmair M, Huber RM, Jacob K, et al. Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J Photochem Photobiol B. 1997;40:313–9.
Popken G, Schultze-Seemann W, Seiler KU, Birkel M, Wetterauer U. Intravesical administration of 5-aminolevulinic acid (5-ALA). Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IX. Eur J Clin Pharmacol. 2000;56:241–6.
Filbeck T, Wimmershoff MB, Pichlmeier U, Karrer S, Wieland WF, Szeimies RM, et al. No generalized skin phototoxicity after intravesical application of 5-aminolevulinic acid for fluorescence diagnosis of superficial bladder cancer. Urol Int. 2000;64:126–8.
Witjes JA, Redorta JP, Jacqmin D, Sofras F, Malmström PU, Riedl C, et al. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol. 2010;57:607–14.
European Association of Urology. Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and CIS). European Association of Urology Guidelines. 2013 edition, pp. 10–16.
Guideline for the management of nonmuscle invasive bladder cancer: (Stages Ta, T1, and Tis). Chapter 1: the management of bladder cancer: diagnosis and treatment recommendations. 2007 Update, pp. 14–15.
Friesen SA, Hjortland GO, Madsen SJ, Hirschberg H, Engebraten O, Nesland JM, et al. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review). Int J Oncol. 2002;21:577–82.
Csanády M, Kiss JG, Iván L, Jóri J, Czigner J. ALA (5-aminolevulinic acid)-induced protoporphyrin IX fluorescence in the endoscopic diagnostic and control of pharyngo-laryngeal cancer. Eur Arch Otorhinolaryngol. 2004;26:262–6.
Namikawa T, Inoue K, Uemura S, Shiga M, Maeda H, Kitagawa H, et al. Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer. J Surg Oncol. 2014;109:213. doi:10.1002/jso.23487.
Kishi K, Fujiwara Y, Yano M, Inoue M, Miyashiro I, Motoori M, et al. Staging laparoscopy using ALA-mediated photodynamic diagnosis improves the detection of peritoneal metastases in advanced gastric cancer. J Surg Oncol. 2012;106:294–8.
Murayama Y, Ichikawa D, Koizumi N, Komatsu S, Shiozaki A, Kuriu Y, et al. Staging fluorescence laparoscopy for gastric cancer by using 5-aminolevulinic acid. Anticancer Res. 2012;32:5421–7.
Messmann H, Knüchel R, Endlicher E, Hauser T, Szeimies RM, Kullmann F, et al. Photodynamic diagnosis of gastrointestinal precancerous lesions after sensitization with 5-aminolevulinic acid. A pilot study. Dtsch Med Wochenschr. 1998;123:515–21.
Baumgartner R, Huber RM, Schulz H, Stepp H, Rick K, Gamarra F, et al. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J Photochem Photobiol B. 1996;36:169–74.
Baas P, Triesscheijn M, Burgers S, van Pel R, Stewart F, Aalders M. Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid. Chest. 2006;129:718–24.
Andikyan V, Kronschnabl M, Hillemanns M, Wang X, Stepp H, Hillemanns P. Fluorescence diagnosis with 5-ALA thermogel of cervical intraepithelial neoplasia. Gynakol Geburtshilfliche Rundsch. 2004;44:31–7.
Fritsch C, Ruzicka T. Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods. J Environ Pathol Toxicol Oncol. 2006;25:425–39.
Muroi C, Fandino J, Coluccia D, Berkmann S, Fathi AR, Landolt H. 5-Aminolevulinic acid fluorescence-guided surgery for spinal meningioma. World Neurosurg. 2013;80:223. pii: S1878-8750(12)01450-7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
There were multiple papillary tumors. ALA-PDD could show red fluorescence of these tumors themselves and also the outskirts of these tumors. In particular, a tiny and flat lesion could be detected only by ALA-PDD in the right posterior wall of urinary bladder. Moreover, the floating of a lot of bladder cancer cells with PDD-fluorescence (MP4 87,401 kb) could be detected.
In TURB, bladder tumor is scraped with the looped type of electrical scalpel under the cystoscopic observation. TURB under ALA-PDD enable to confirm the correct surgical margin by navigation of red fluorescence. The residual lesions with red fluorescence at the resected margin could be resected additionally and exactly (MP4 201,878 kb)
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Inoue, K., Fukuhara, H., Shuin, T. (2015). Photodynamic Diagnosis Mediated by 5-Aminolevulinic Acid for Urinary Bladder Cancer. In: Dip, F., Ishizawa, T., Kokudo, N., Rosenthal, R. (eds) Fluorescence Imaging for Surgeons. Springer, Cham. https://doi.org/10.1007/978-3-319-15678-1_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-15678-1_30
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15677-4
Online ISBN: 978-3-319-15678-1
eBook Packages: MedicineMedicine (R0)